Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

460 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Fertility drugs, reproductive strategies and ovarian cancer risk.
Tomao F, Lo Russo G, Spinelli GP, Stati V, Prete AA, Prinzi N, Sinjari M, Vici P, Papa A, Chiotti MS, Benedetti Panici P, Tomao S. Tomao F, et al. Among authors: benedetti panici p. J Ovarian Res. 2014 May 8;7:51. doi: 10.1186/1757-2215-7-51. eCollection 2014. J Ovarian Res. 2014. PMID: 24829615 Free PMC article. Review.
Immunogenicity of allo-vesicle carrying ERBB2 tumor antigen for dendritic cell-based anti-tumor immunotherapy.
Napoletano C, Rughetti A, Landi R, Pinto D, Bellati F, Rahimi H, Spinelli GP, Pauselli S, Sale P, Dolo V, De Lorenzo F, Tomao F, Benedetti-Panici P, Frati L, Nuti M. Napoletano C, et al. Among authors: benedetti panici p. Int J Immunopathol Pharmacol. 2009 Jul-Sep;22(3):647-58. doi: 10.1177/039463200902200310. Int J Immunopathol Pharmacol. 2009. PMID: 19822081 Free article.
Epistaxis in weekly paclitaxel regimen: Is it really related to schedule?
Perniola G, Marchetti C, Caradio F, Tomao F, Benedetti Panici P. Perniola G, et al. Among authors: benedetti panici p. Basic Clin Pharmacol Toxicol. 2011 Feb;108(2):77-8. doi: 10.1111/j.1742-7843.2010.00641.x. Epub 2010 Nov 12. Basic Clin Pharmacol Toxicol. 2011. PMID: 21073658 Free article. No abstract available.
Current knowledge and open issues regarding bevacizumab in gynaecological neoplasms.
Bellati F, Napoletano C, Gasparri ML, Ruscito I, Marchetti C, Pignata S, Tomao F, Benedetti Panici P, Nuti M. Bellati F, et al. Among authors: benedetti panici p. Crit Rev Oncol Hematol. 2012 Jul;83(1):35-46. doi: 10.1016/j.critrevonc.2011.09.006. Epub 2011 Nov 4. Crit Rev Oncol Hematol. 2012. PMID: 22056314 Review.
Olaparib, PARP1 inhibitor in ovarian cancer.
Marchetti C, Imperiale L, Gasparri ML, Palaia I, Pignata S, Boni T, Bellati F, Benedetti Panici P. Marchetti C, et al. Among authors: benedetti panici p. Expert Opin Investig Drugs. 2012 Oct;21(10):1575-84. doi: 10.1517/13543784.2012.707189. Epub 2012 Jul 13. Expert Opin Investig Drugs. 2012. PMID: 22788971 Review.
Beyond bevacizumab: investigating new angiogenesis inhibitors in ovarian cancer.
Tomao F, Papa A, Rossi L, Caruso D, Zoratto F, Benedetti Panici P, Tomao S. Tomao F, et al. Among authors: benedetti panici p. Expert Opin Investig Drugs. 2014 Jan;23(1):37-53. doi: 10.1517/13543784.2013.839657. Epub 2013 Oct 11. Expert Opin Investig Drugs. 2014. PMID: 24111925 Review.
460 results